ClassID:

21647

A61K2300/00 - page 7 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#1801
20180303760
2018-10-25

Antigen-specific, tolerance-inducing microparticles and uses thereof

#1802
20180303147
2018-10-25

Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult

#1803
20180298084
2018-10-18

BACTERICIDAL MONOCLONAL ANTIBODY TARGETING KLEBSIELLA PNEUMONIAE

#1804
20180298022
2018-10-18

Tetrandrine family pharmaceutical formulations and method

#1805
20180298019
2018-10-18

Salt of EGFR inhibitor, crystalline form and uses thereof

#1806
20180298000
2018-10-18

AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY

#1807
20180297991
2018-10-18

Ferroportin inhibitors

#1808
20180297986
2018-10-18

Compounds and compositions as protein kinase inhibitors

#1809
20180297985
2018-10-18

Compounds and compositions as protein kinase inhibitors

#1810
20180297982
2018-10-18

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

#1811
20180297965
2018-10-18

Compositions and methods for treating cancers

#1812
20180297931
2018-10-18

Compositions and methods for the treatment of fatty acid metabolism disorders

#1813
20180297839
2018-10-18

ARTICLES COMPRISING NANO-MATERIALS FOR GEOMETRY-GUIDED STEM CELL DIFFERENTIATION AND ENHANCED BONE GROWTH

#1814
20180296676
2018-10-18

PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF

#1815
20180296646
2018-10-18

TREATMENT OF EPITHELIAL LAYER LESIONS

#1816
20180296643
2018-10-18

SDF-1 FOR ANAL AND SPHINCTER WOUND HEALING

#1817
20180296640
2018-10-18

Peptides and method for treatment of cardiac arrest

#1818
20180296634
2018-10-18

Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors

#1819
20180296621
2018-10-18

Composition for the prevention and/or treatment of allergy symptoms

#1820
20180296614
2018-10-18

Combination treatment

#1821
20180296609
2018-10-18

MAPC treatment of brain injuries and diseases

#1822
20180296605
2018-10-18

Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis

#1823
20180296599
2018-10-18

Trace element solution

#1824
20180296597
2018-10-18

TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS

#1825
20180296594
2018-10-18

SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS

#1826
20180296593
2018-10-18

Peritoneal dialysis fluid

#1827
20180296591
2018-10-18

Compositions and methods for treating conditions of compromised skin barrier function

#1828
20180296587
2018-10-18

Compositions of and methods of treatment with zwitterionic polysaccharide

#1829
20180296580
2018-10-18

Method for treating cancer using dual antagonists of CXCR1 and CXCR2

#1830
20180296567
2018-10-18

METHODS FOR TREATING INTRAPULMONARY INFECTIONS

#1831
20180296565
2018-10-18

Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof

#1832
20180296554
2018-10-18

Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

#1833
20180296551
2018-10-18

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

#1834
20180296550
2018-10-18

Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

#1835
20180296540
2018-10-18

METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA

#1836
20180296531
2018-10-18

STIMULATION OF 11B-HSD2 EXPRESSION TO IMPROVE HORMONAL THERAPY OF STEROID-DEPENDENT DISEASE

#1837
20180296528
2018-10-18

PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#1838
20180296520
2018-10-18

Method for treating paroxysmal nocturnal hemoglobinuria

#1839
20180296519
2018-10-18

Sacubitril calcium salts

#1840
20180296516
2018-10-18

Amino acid compositions and methods for the treatment of liver diseases

#1841
20180296505
2018-10-18

BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS

#1842
20180296500
2018-10-18

Treatment of prostate carcinoma

#1843
20180296483
2018-10-18

Microvesicles derived from nucleated, mammalian cells and use thereof

#1844
20180291452
2018-10-11

Methods for diagnosis of tuberculosis

#1845
20180291380
2018-10-11

USP30 INHIBITORS AND METHODS OF USE

#1846
20180291087
2018-10-11

IgG stimulated remyelination of peripheral nerves

#1847
20180291075
2018-10-11

Use of IL-15 to increase thymic output and to treat lymphopenia

#1848
20180291039
2018-10-11

Beta-lactamase inhibitors

#1849
20180291030
2018-10-11

NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS

#1850
20180290998
2018-10-11

METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES

#1851
20180290985
2018-10-11

Quinoxalinyl-piperazinamide methods of use

#1852
20180290972
2018-10-11

Isothiocyanate functional surfactant and associated method of use

#1853
20180289957
2018-10-11

Remineralisation of calcified tissue

#1854
20180289956
2018-10-11

REMINERALISATION OF CALCIFIED TISSUE

#1855
20180289814
2018-10-11

Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke

#1856
20180289813
2018-10-11

Controlled drug release from electrospun fibers

#1857
20180289810
2018-10-11

Sustained release eye drop formulations

#1858
20180289803
2018-10-11

Anti-PD-L1-anti-TIM-3 bispecific antibodies

#1859
20180289801
2018-10-11

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

#1860
20180289776
2018-10-11

Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant

#1861
20180289773
2018-10-11

COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION

#1862
20180289769
2018-10-11

Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist

#1863
20180289767
2018-10-11

Compositions and methods for invasive and non-invasive procedural skincare

#1864
20180289763
2018-10-11

Composition containing herbal medicine extracts of Pinellia and Scutellaria for reducing side effects due to anticancer drugs

#1865
20180289760
2018-10-11

Herbal supplements and methods of use thereof

#1866
20180289739
2018-10-11

Combination Therapy for Treating Proliferative Diseases

#1867
20180289738
2018-10-11

ENHANCED IMMUNE RESPONSE IN CATTLE UPON TREATMENT WITH NITRIC OXIDE

#1868
20180289737
2018-10-11

ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND

#1869
20180289735
2018-10-11

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS

#1870
20180289729
2018-10-11

COMBINATION THERAPY FOR TREATMENT OF HUMAN NEURODEGENERATIVE DISEASES

#1871
20180289723
2018-10-11

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

#1872
20180289719
2018-10-11

COMPOSITION

#1873
20180289714
2018-10-11

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

#1874
20180289712
2018-10-11

COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

#1875
20180289708
2018-10-11

Low dose oral dipyridamole compositions and uses thereof

#1876
20180289693
2018-10-11

Methods for inducing apoptosis in cancer cells

#1877
20180289680
2018-10-11

Azetidine derivative, preparation method therefor, and use thereof

#1878
20180289676
2018-10-11

COMPOUNDS AND METHODS TARGETING GPER IN CANCER

#1879
20180289670
2018-10-11

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#1880
20180289659
2018-10-11

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

#1881
20180289658
2018-10-11

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

#1882
20180289657
2018-10-11

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

#1883
20180289656
2018-10-11

COMPOSITIONS AND METHODS TO TREAT URINARY TRACT INFECTIONS

#1884
20180289655
2018-10-11

Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases

#1885
20180289653
2018-10-11

LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND A NON-FATTY ACID ANTI-INFLAMMATORY AGENT

#1886
20180289652
2018-10-11

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#1887
20180289649
2018-10-11

Dosage forms and therapeutic uses of L-4-chlorokynurenine

#1888
20180289644
2018-10-11

Solid-forming local anesthetic formulations for pain control

#1889
20180289633
2018-10-11

Composition and method for treating skin conditions

#1890
20180289632
2018-10-11

Treatment of addiction and impulse-control disorders using PDE7 inhibitors

#1891
20180289627
2018-10-11

Nanoparticles, composition and system for delivering 5FU and uses thereof

#1892
20180289609
2018-10-11

Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar

#1893
20180282363
2018-10-04

GLUCOPYRANOSIDE COMPOUND

#1894
20180282345
2018-10-04

Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer

#1895
20180282331
2018-10-04

7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS

#1896
20180282304
2018-10-04

RORC2 INHIBITORS AND METHODS OF USE THEREOF

#1897
20180282281
2018-10-04

IMMUNOREGULATORY AGENTS

#1898
20180280511
2018-10-04

Continudihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods

#1899
20180280507
2018-10-04

Polynucleotides encoding humanized anti-CD40 antibodies

#1900
20180280498
2018-10-04

Aluminum based adjuvants for tolerogenic vaccination

#1901
20180280481
2018-10-04

Pharmaceutical formulations for the oral delivery of peptide drugs

#1902
20180280476
2018-10-04

DIAGNOSTIC BIOMARKERS FOR FIBROTIC DISORDERS

#1903
20180280464
2018-10-04

Compositions and Methods for Pain Relief

#1904
20180280463
2018-10-04

Process to enhance the bioactivity of ashwagandha extracts

#1905
20180280462
2018-10-04

USE OF FLAXSEED AND FLAXSEED DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS AND VIRAL DISEASES

#1906
20180280448
2018-10-04

Formulation for targeting cancer in humans and canines

#1907
20180280445
2018-10-04

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

#1908
20180280432
2018-10-04

METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE

#1909
20180280417
2018-10-04

Method of treating bacterial infections

#1910
20180280416
2018-10-04

Dosage forms for oral administration of zoledronic acid or related compounds for treating disease

#1911
20180280410
2018-10-04

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

#1912
20180280395
2018-10-04

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#1913
20180280393
2018-10-04

METHODS AND COMPOSITIONS FOR TREATMENT OF METASTATIC AND REFRACTORY CANCERS AND TUMORS

#1914
20180280387
2018-10-04

SYK INHIBITORS

#1915
20180280380
2018-10-04

Combination of opioids and anticancer drugs for cancer treatment

#1916
20180280379
2018-10-04

Trilobine and its natural analogs for use as a drug

#1917
20180280377
2018-10-04

Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer

#1918
20180280374
2018-10-04

PHARMACEUTICAL COMPOSITIONS

#1919
20180280364
2018-10-04

PHARMACEUTICAL COMPOSITIONS OF SODIUM PICOSULFATE, MAGNESIUM OXIDE AND CITRIC ACID

#1920
20180280361
2018-10-04

Combinations of isomers of dihydrotetrabenazine

#1921
20180280359
2018-10-04

Uses of combinations (+)-α-dihydrotetrabenazine and (−)-α-dihydrotetrabenazine in methods of treating movement disorder

#1922
20180280358
2018-10-04

Methods of treatment for cholestatic and fibrotic diseases

#1923
20180280350
2018-10-04

Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions

#1924
20180280343
2018-10-04

TOPICAL SILIBININ FORMULATIONS AND USES THEREFOR

#1925
20180280326
2018-10-04

MEDICAMENT FOR PREVENTING OR INHIBITING ACUTE KIDNEY INJURY

#1926
20180280324
2018-10-04

Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma

#1927
20180280317
2018-10-04

METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL

#1928
20180280297
2018-10-04

No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne

#1929
20180280289
2018-10-04

IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS

#1930
20180279613
2018-10-04

Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals

#1931
20180273941
2018-09-27

Short non-coding protein regulatory RNAs (sprRNAs) and methods of use

#1932
20180273618
2018-09-27

Combination therapy for treatment of disease

#1933
20180273580
2018-09-27

7-dehydrocholesterol derivatives and methods using same

#1934
20180273474
2018-09-27

Compositions for preventing and/or treating degenerative disorders of the central nervous system

#1935
20180272001
2018-09-27

Anti-cancer and anti-inflammatory therapeutics and methods thereof

#1936
20180271992
2018-09-27

Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51

#1937
20180271980
2018-09-27

Drug device configured for wireless communication

#1938
20180271974
2018-09-27

Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response

#1939
20180271951
2018-09-27

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

#1940
20180271946
2018-09-27

SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS

#1941
20180271940
2018-09-27

Combined preparations for the treatment of cancer or infection

#1942
20180271925
2018-09-27

Method for improving gingivitis and periodontitis by antibacterial, antioxidant and anti-inflammatory effects and inhibition of alveolar bone loss of complex extracts of moringa leaf and eucommia bark

#1943
20180271903
2018-09-27

Methods for treatment of diarrhea

#1944
20180271902
2018-09-27

Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease

#1945
20180271897
2018-09-27

LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE

#1946
20180271889
2018-09-27

Combination therapy for cancer

#1947
20180271886
2018-09-27

TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

#1948
20180271885
2018-09-27

Stabilized modified release vitamin D formulation and method of administering same

#1949
20180271884
2018-09-27

Stabilized modified release vitamin D formulation and method of administering same

#1950
20180271860
2018-09-27

Pharmaceutical compounds

#1951
20180271842
2018-09-27

Methods of treating hepatic encephalopathy

#1952
20180271834
2018-09-27

Phytoestrogen compositions and associated methods

#1953
20180271822
2018-09-27

Compositions and methods of use of phorbol esters for the treatment of stroke

#1954
20180271811
2018-09-27

Composition containing glibenclamide

#1955
20180271807
2018-09-27

Meglumine in Combination with Another Therapeutic

#1956
20180271787
2018-09-27

COMBINATION METHODS AND COMPOSITIONS

#1957
20180271781
2018-09-27

Compositions and methods for treating pterygium

#1958
20180271780
2018-09-27

Compositions and methods for treating hyperemia

#1959
20180265536
2018-09-20

Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

#1960
20180265522
2018-09-20

Marinopyrrole derivatives and methods of making and using same

#1961
20180265512
2018-09-20

FUSED PYRIMIDINE-BASED HYDROXAMATE DERIVATIVES

#1962
20180264387
2018-09-20

Filter precleaner

#1963
20180264292
2018-09-20

Skincare compositions

#1964
20180264079
2018-09-20

Immune checkpoint inhibitor combinations

#1965
20180264069
2018-09-20

Composition for prevention, alleviation or treatment of precocious puberty containing extract of coicis semen and artemisia capillaris as active ingredient

#1966
20180264062
2018-09-20

Process for preparing herbal extracts

#1967
20180264051
2018-09-20

Pharmaceutical wound healing composition

#1968
20180264042
2018-09-20

TREATMENT AND PROPHYLAXIS OF RADIATION DERMATITIS

#1969
20180264032
2018-09-20

COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS

#1970
20180264017
2018-09-20

Carborane compounds and methods of use thereof

#1971
20180264014
2018-09-20

Compositions and methods for treating multiple sclerosis

#1972
20180264013
2018-09-20

COMPOSITION AND METHODS FOR TREATING SLEEP DISORDERS

#1973
20180264008
2018-09-20

COMBINATION

#1974
20180264007
2018-09-20

PHARMACEUTICAL COMPOSITION

#1975
20180264004
2018-09-20

Chemoimmunotherapy for epithelial cancer

#1976
20180264003
2018-09-20

Inhibitors of the plasmodial surface anion channel as antimalarials

#1977
20180263990
2018-09-20

CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY

#1978
20180263989
2018-09-20

THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE

#1979
20180263985
2018-09-20

MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV

#1980
20180263982
2018-09-20

Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

#1981
20180263979
2018-09-20

COMBINATION OF RAF INHIBITORS AND AURORA KINASE INHIBITORS

#1982
20180263976
2018-09-20

Composition and method for treatment of depression and psychosis in humans

#1983
20180263971
2018-09-20

Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

#1984
20180263968
2018-09-20

METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF MANTLE CELL LYMPHOMAS

#1985
20180263963
2018-09-20

Modulators of the adenosine A3 receptors

#1986
20180263950
2018-09-20

Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compounds

#1987
20180263947
2018-09-20

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#1988
20180263946
2018-09-20

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

#1989
20180263940
2018-09-20

TREATMENT OF SKIN CONDITIONS

#1990
20180263937
2018-09-20

USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS

#1991
20180263936
2018-09-20

GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS

#1992
20180263931
2018-09-20

Topical dapsone and dapsone/adaplene compositions and methods for use thereof

#1993
20180263916
2018-09-20

SOFT GELATIN CAPSULES CONTAINING A MIXTURE OF ANALGESICS AND DECONGESTANTS, EXPECTORANTS, ANTITUSSIVES AND/OR ANTIHISTAMINES

#1994
20180263914
2018-09-20

COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS

#1995
20180263906
2018-09-20

NRF2 Screening Assays and Related Methods and Compositions

#1996
20180263901
2018-09-20

Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application

#1997
20180263899
2018-09-20

Intrauterine delivery system for contraception

#1998
20180263892
2018-09-20

Topical skin care formulations comprising plant extracts

#1999
20180258460
2018-09-13

Inhibition and treatment of gastrointestinal biofilms

#2000
20180258173
2018-09-13

Bispecific EGFR/C-Met Antibodies

#2001
20180258169
2018-09-13

Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma

#2002
20180258130
2018-09-13

D-amino acid compounds for liver disease

#2003
20180258102
2018-09-13

Benzodiazepine derivatives as RSV inhibitors

#2004
20180258100
2018-09-13

RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY

#2005
20180258098
2018-09-13

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#2006
20180258089
2018-09-13

Processes for preparing a diazabicyclooctane compound

#2007
20180256751
2018-09-13

ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

#2008
20180256748
2018-09-13

Nucleic acid products and methods of administration thereof

#2009
20180256710
2018-09-13

Anti-S100A8 for treating leukemia

#2010
20180256664
2018-09-13

Composition for preventing or treating stroke or degenerative brain disease

#2011
20180256660
2018-09-13

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

#2012
20180256656
2018-09-13

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT

#2013
20180256640
2018-09-13

MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF

#2014
20180256624
2018-09-13

Methods and compositions for the activation of gamma-delta T-cells

#2015
20180256621
2018-09-13

Composition of trigofoenoside and flavonoids and methods thereof

#2016
20180256618
2018-09-13

Antiviral supplement formulations

#2017
20180256617
2018-09-13

METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES

#2018
20180256598
2018-09-13

Vaginal inserted estradiol pharmaceutical compositions and methods

#2019
20180256583
2018-09-13

Treatments for autoimmune disease

#2020
20180256580
2018-09-13

Combination therapies for treatment of cancer

#2021
20180256579
2018-09-13

Methods and compositions for treating drug resistance in cancer

#2022
20180256578
2018-09-13

Combination therapy comprising varlitinib and an anticancer agent

#2023
20180256567
2018-09-13

Compositions and methods for treating centrally mediated nausea and vomiting

#2024
20180256557
2018-09-13

PHARMACEUTICAL COMBINATION COMPRISING (A) THE ALPHA-ISOFORM SPECIFIC PI3K INHIBITOR ALPELISIB (BYL719) AND (B) AN AKT INHIBITOR, PREFERABLY MK-2206, AFURESERTIB OR UPROSERTIB, AND THE USE THEREOF IN THE TREATMENT/PREVENTION OF CANCER

#2025
20180256552
2018-09-13

METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS

#2026
20180256551
2018-09-13

METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

#2027
20180256542
2018-09-13

PREPARATION AND USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS

#2028
20180256532
2018-09-13

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

#2029
20180256526
2018-09-13

Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases

#2030
20180256524
2018-09-13

COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS

#2031
20180256519
2018-09-13

COMPOSITION FOR PREVENTING OR TREATING MITOCHONDRIAL DISEASES CAUSED BY IMMUNOSUPPRESSANTS, AND IMMUNE DISEASES, CONTAINING METFORMIN

#2032
20180256518
2018-09-13

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#2033
20180256496
2018-09-13

CONTROLLED-RELEASE FORMULATIONS

#2034
20180256493
2018-09-13

IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS

#2035
20180251548
2018-09-06

COMPOSITIONS AND METHODS FOR TREATING CANCER VIA ANTAGONISM OF THE CD155/TIGIT PATHWAY AND TGF-BETA

#2036
20180251455
2018-09-06

Indolin-2-one derivatives

#2037
20180251453
2018-09-06

Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereof

#2038
20180251451
2018-09-06

Indolin-2-one derivatives

#2039
20180251450
2018-09-06

Indolin-2-one derivatives

#2040
20180251449
2018-09-06

Indolin-2-one derivatives

#2041
20180250443
2018-09-06

Biomimetic hybrid gel compositions and methods of use

#2042
20180250419
2018-09-06

Compositions and methods for treating cardiovascular related disorders

#2043
20180250405
2018-09-06

Compositions, combinations and related methods for photoimmunotherapy

#2044
20180250397
2018-09-06

Adjuvant treatment of HER2-positive breast cancer

#2045
20180250384
2018-09-06

Immunogenic antigen identification from a pathogen and correlation to clinical efficacy

#2046
20180250366
2018-09-06

Compositions and methods for protecting the kidney from ischemia reperfusion injury

#2047
20180250359
2018-09-06

COMBINATION THERAPY USING GLIADIN AND GAMMA AMINOBUTYRIC ACID

#2048
20180250351
2018-09-06

Cyanobacterial microalgae phycocyanin and phycocyanobilin to beneficially inhibit the activity of the UDP-GDH enzyme while significantly increasing the absorption and circulation of curcumin

#2049
20180250337
2018-09-06

Genetically engineered drug resistant T cells and methods of using the same

#2050
20180250336
2018-09-06

COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS

#2051
20180250334
2018-09-06

Trace elements

#2052
20180250326
2018-09-06

Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin

#2053
20180250324
2018-09-06

PREBIOTIC FORMULATIONS AND METHODS OF USE

#2054
20180250320
2018-09-06

COMPOSITIONS AND METHODS FOR TREATING SOLID TUMORS

#2055
20180250318
2018-09-06

Synergistic composition for maintenance of healthy balance of microflora

#2056
20180250315
2018-09-06

Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome

#2057
20180250308
2018-09-06

NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES

#2058
20180250302
2018-09-06

COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER

#2059
20180250301
2018-09-06

Combination therapy of an HBV capsid assembly inhibitor and an interferon

#2060
20180250299
2018-09-06

Use of kinase inhibitors to manage tuberculosis and other infectious diseases

#2061
20180250295
2018-09-06

Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease Treatments

#2062
20180250292
2018-09-06

ANTIBIOTIC GEL FORMULATION AND METHODS OF PREPARING THE ANTIBIOTIC GEL FORMULATION

#2063
20180250291
2018-09-06

Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use

#2064
20180250290
2018-09-06

Compositions for treating CMT and related disorders

#2065
20180250285
2018-09-06

COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE

#2066
20180250281
2018-09-06

TRANSDERMAL DELIVERY OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

#2067
20180250279
2018-09-06

Methods for treatment of fabry disease

#2068
20180250276
2018-09-06

Antibacterial compounds

#2069
20180250271
2018-09-06

Pharmaceutical antiretroviral composition

#2070
20180250270
2018-09-06

MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM

#2071
20180250263
2018-09-06

Therapeutic combinations of sesquiterpenes and flavonoids

#2072
20180250262
2018-09-06

SUSTAINED RELEASE CANNABINOID FORMULATIONS

#2073
20180250261
2018-09-06

METHOD FOR TREATING CANCER WITH A STAT3 PATHWAY INHIBITOR AND KINASE INHIBITOR

#2074
20180250246
2018-09-06

PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES

#2075
20180250228
2018-09-06

Highly stable non-vesicular nanoparticles and application thereof in treating microbial infection

#2076
20180250215
2018-09-06

Topical application of dihydrotestosterone and testosterone fixed combination formulation for promoting hair growth containing formulations

#2077
20180250214
2018-09-06

Topical dihydrotestosterone (DHT) for promoting hair growth-containing formulations

#2078
20180246123
2018-08-30

A COMPOSITION COMPRISING PROSTACYCLIN ANDOR ANALOGUES THEREOF FOR TREATMENT OF ACUTE CRITICALLY ILL PATIENTS

#2079
20180244794
2018-08-30

ASSESSING AND TREATING LYMPHOMA

#2080
20180244771
2018-08-30

Immunity enhancing agent for cancer by Allergin-1 antagonist

#2081
20180244690
2018-08-30

Oxabicycloheptane prodrugs

#2082
20180244683
2018-08-30

ANTIVIRAL COMPOUNDS

#2083
20180244642
2018-08-30

MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF

#2084
20180243441
2018-08-30

Cytotoxic HEXIM1 peptides and uses thereof

#2085
20180243419
2018-08-30

Liposomal compositions with light illumination-induced drug release

#2086
20180243373
2018-08-30

Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations

#2087
20180243362
2018-08-30

Method for producing dry extracts

#2088
20180243359
2018-08-30

Synergistic antibacterial effects of magnolia bark extract and L-arginine, N--lauroyl ethyl ester on plaque biofilm

#2089
20180243358
2018-08-30

Composition containing angelica extract for promoting proliferation of stem cells derived from bone marrow

#2090
20180243333
2018-08-30

Bicarbonate as a potentiator for antimicrobial agents

#2091
20180243332
2018-08-30

Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

#2092
20180243330
2018-08-30

Method of treating severe asthma

#2093
20180243319
2018-08-30

Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

#2094
20180243317
2018-08-30

COMPOSITIONS COMPRISING A PI3K INHIBITOR AND AN HDAC INHIBITOR

#2095
20180243308
2018-08-30

PHARMACEUTICAL COMBINATION

#2096
20180243302
2018-08-30

Varlitinib for use in the treatment of resistant or refractory cancer

#2097
20180243291
2018-08-30

DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION

#2098
20180243288
2018-08-30

Compositions and methods for weight loss in at risk patient populations

#2099
20180243279
2018-08-30

Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF inhibitor dabrafenib; the use of such combination in the treatment or prevention of cancer

#2100
20180243274
2018-08-30

ANTIBACTERIAL COMPOSITIONS